Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SCHWARZINGER I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 79 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laczika, K; Mitterbauer, G; Mitterbauer, M; Knobl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
      Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions

      LEUKEMIA & LYMPHOMA
    2. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
      Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells

      LEUKEMIA & LYMPHOMA
    3. Sperr, WR; Wimazal, F; Kundi, M; Fonatsch, C; Thalhammer-Scherrer, R; Schernthaner, GH; Schwarzinger, I; Haas, OA; Geissler, K; Lechner, K; Valent, P
      Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems

      ANNALS OF HEMATOLOGY
    4. Keil, F; Prinz, F; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jager, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Hocker, P; Greinix, HT
      Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

      LEUKEMIA
    5. Wimazal, F; Sperr, WR; Kundi, M; Meidlinger, P; Fonatsch, C; Jordan, JH; Thalhammer-Scherrer, R; Schwarzinger, I; Geissler, K; Lechner, K; Valent, P
      Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes

      LEUKEMIA RESEARCH
    6. Wagner, T; Schwartz, DWM; Winter, M; Kabrna, E; Kollars, M; Schwarzinger, I; Lanzer, G; Mayr, WR; Geissler, K
      Kinetics of CFU-Mk after automated plateletpheresis

      VOX SANGUINIS
    7. Exner, M; Schwarzinger, I
      Targeting the dust

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Ruzicka, K; Veitl, M; Thalhammer-Scherrer, R; Schwarzinger, I
      The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    9. Reiter, E; Greinix, H; Rabitsch, W; Keil, F; Schwarzinger, I; Jaeger, U; Lechner, K; Worel, N; Streubel, B; Fonatsch, C; Mitterbauer, G; Kalhs, P
      Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26)

      ANNALS OF HEMATOLOGY
    10. Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jager, U; Rosenmayr, A; Knobl, P; Schwarzinger, I; Hocker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
      Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

      ANNALS OF HEMATOLOGY
    11. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
      Fludarabine therapy in Waldenstrom's macroglobulinemia

      ANNALS OF HEMATOLOGY
    12. Schwarzinger, I; Speiser, W; Lubenow, N; Greinacher, A; Panzer, S
      Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: Coincidence or association?

      THROMBOSIS AND HAEMOSTASIS
    13. Exner, M; Schwarzinger, I
      Untitled - Reply

      CYTOMETRY
    14. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
      The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?

      CYTOMETRY
    15. Thalhammer-Scherrer, R; Veitl, M; Exner, M; Schneider, B; Geissler, K; Simonitsch, I; Schwarzinger, I
      Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice

      CYTOMETRY
    16. Mitterbauer, G; Zimmer, C; Pirc-Danoewinata, H; Haas, OA; Hojas, S; Schwarzinger, I; Greinix, H; Jager, U; Lechner, K; Mannhalter, C
      Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction

      BRITISH JOURNAL OF HAEMATOLOGY
    17. Mitterbauer, M; Laczika, K; Novak, M; Mitterbauer, G; Hilgarth, B; Pirc-Danoewinata, H; Schwarzinger, I; Haas, OA; Fonatsch, C; Lechner, K; Jaeger, U
      High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia - A single center study

      AJCP. American journal of clinical pathology
    18. Reiter, E; Greinix, HT; Keil, F; Brugger, S; Rabitsch, W; Schulenburg, A; Mannhalter, C; Schwarzinger, I; Worel, N; Volc-Platzer, B; Fischer, G; Dieckmann, K; Hinterberger, W; Schneider, B; Haas, OA; Geissler, K; Kalhs, P
      Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    19. Stohlawetz, P; Schulenburg, A; Stiegler, G; Panzer, S; Hocker, P; Kalhs, P; Schwarzinger, I; Mullauer, L; Simonitsch, I; Geissler, K; Jilma, B
      The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients

      EUROPEAN JOURNAL OF HAEMATOLOGY
    20. Thalhammer-Scherrer, R; Wieselthaler, G; Knoebl, P; Schwarzinger, I; Simonitsch, I; Mitterbauer, G; Berlakovich, GA; Mannhalter, C; Haas, OA; Mayer, G; Muehlbacher, F; Wolner, E; Klepetko, W; Lechner, K; Jaeger, U
      Post-transplant acute myeloid leukemia (PT-AML)

      LEUKEMIA
    21. Mitterbauer, G; Zimmer, C; Fonatsch, C; Haas, OA; Thalhammer-Scherrer, R; Schwarzinger, I; Kahls, P; Jaeger, U; Lechner, K; Mannhalter, C
      Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR

      LEUKEMIA
    22. Wimazal, F; Sperr, WR; Horny, HP; Carroll, V; Binder, BR; Fonatsch, C; Walchshofer, S; Fodinger, M; Schwarzinger, I; Samorapoompichit, P; Chott, A; Dvorak, AM; Lechner, K; Valent, P
      Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells

      AMERICAN JOURNAL OF HEMATOLOGY
    23. Kalhs, P; Brugger, S; Reiter, E; Keil, F; Fischer, G; Schulenburg, A; Rabitsch, W; Rosenmayr, A; Dieckmann, K; Kurz, M; Schwarzinger, I; Volc-Platzer, B; Mannhalter, C; Lechner, K; Greinix, HT
      Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia

      BONE MARROW TRANSPLANTATION
    24. Mitterbauer, G; Nemeth, P; Wacha, S; Cross, NCP; Schwarzinger, I; Jaeger, U; Geissler, K; Greinix, HT; Kalhs, P; Lechner, K; Mannhalter, C
      Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

      BRITISH JOURNAL OF HAEMATOLOGY
    25. MITTERBAUER M; KUSEC R; SCHWARZINGER I; HAAS OA; LECHNER K; JAEGER U
      COMPARISON OF KARYOTYPE ANALYSIS AND RT PCR FOR AML1 ETO IN 204 UNSELECTED PATIENTS WITH AML/

      Annals of hematology
    26. Reiter, E; Greinix, HT; Mitterbauer, G; Fischer, G; Keil, F; Mannhalter, C; Rabitsch, W; Schwarzinger, I; Worel, N; Lechner, K; Kalhs, P
      Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia

      ANNALS OF HEMATOLOGY
    27. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    28. LACZIKA K; NOVAK M; HILGARTH B; MITTERBAUER M; MITTERBAUER G; SCHEIDELPETROVIC A; SCHOLTEN C; THALHAMMERSCHERRER R; BRUGGER S; KEIL F; SCHWARZINGER I; HAAS OA; LECHNER K; JAEGER U
      COMPETITIVE CBF-BETA MYH11 REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION FOR QUANTITATIVE ASSESSMENT OF MINIMAL RESIDUAL DISEASE DURING POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA WITH INVERSION(16) - A PILOT-STUDY/

      Journal of clinical oncology
    29. REITER E; GREINIX HT; SCHULENBURG A; KEIL F; RABITSCH W; MANNHALTER C; SCHWARZINGER I; FISCHER G; LEITNER G; DIECKMANN K; SCHNEIDER B; LECHNER K; KALHS P
      LONG-TERM LEUKEMIA-FREE SURVIVAL (LFS) AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    30. Reiter, E; Greinix, HT; Brugger, S; Keil, F; Rabitsch, W; Mannhalter, C; Schwarzinger, I; Hocker, P; Fischer, G; Dieckmann, M; Hinterberger, W; Linkesch, W; Schneider, B; Lechner, K; Kalhs, P
      Long term follow up after allogeneic stem cell transplantation for chronicmyelogenous leukemia

      BONE MARROW TRANSPLANTATION
    31. KORNINGER L; MUSTAFA G; SCHWARZINGER I
      THE HEMATOLOGY ANALYZER SF-3000 - PERFORMANCE OF THE AUTOMATED WHITE BLOOD-CELL DIFFERENTIAL COUNT IN COMPARISON TO THE HEMATOLOGY ANALYZERNE-1500

      Clinical and laboratory haematology
    32. WIMAZAL F; WALCHSHOFER S; BAGHESTANIAN M; CHOTT A; SPERR WR; KOPP C; SILLABER C; SEMPER H; HORNY HP; TRONDLE U; FODINGER M; SCHWARZINGER I; LECHNER K; VALENT P
      DETECTION OF MI TRANSCRIPTION FACTOR (MITF) MESSENGER-RNA IN A CASE OF MYELODYSPLASTIC SYNDROME AND BONE-MARROW MASTOCYTOSIS

      Wiener Klinische Wochenschrift
    33. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    34. Sperr, WR; Walchshofer, S; Horny, HP; Fodinger, M; Simonitsch, I; Fritsche-Polanz, R; Schwarzinger, I; Tschachler, E; Sillaber, C; Hagen, W; Geissler, K; Chott, A; Lechner, K; Valent, P
      Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val

      BRITISH JOURNAL OF HAEMATOLOGY
    35. SCHWARZINGER I
      THE HAMA-COM LABORATORY DATA MANAGEMENT-SYSTEM (LDS) - TAILOR-MADE COMPUTERIZATION OF THE INDIVIDUAL WORKING PROCEDURES ARISING IN A HEMATOLOGY LABORATORY WITH A HIGH-THROUGHPUT OF PATHOLOGICAL SAMPLES

      Annals of hematology
    36. MITTERBAUER G; SCHWARZMEIER J; MITTERBAUER M; JAEGER U; FRITSCH G; SCHWARZINGER I
      MYELODYSPLASTIC SYNDROME ACUTE MYELOID-LEUKEMIA SUPERVENING PREVIOUSLY UNTREATED CHRONIC B-LYMPHOCYTIC LEUKEMIA - DEMONSTRATION OF THE CONCOMITANT PRESENCE OF 2 DIFFERENT MALIGNANT CLONES BY IMMUNOLOGICAL AND MOLECULAR ANALYSIS

      Annals of hematology
    37. KNOBL P; RINTELEN C; KORNEK G; WILTSCHKE C; KALHS P; SCHWARZINGER I; GLOBITS S; STAUDINGER T; LACZIKA K; KYRLE P; FRASS M
      PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS

      Intensive care medicine
    38. ZOCHBAUER S; SCHWARZINGER I; STROBL H; LECHNER K; PIRKER R
      RELATIONSHIP BETWEEN MDR1 GENE AND SURFACE-MARKERS IN ACUTE MYELOID-LEUKEMIA

      Anticancer research
    39. JILMA B; SZALAY T; DIRNBERGER E; EICHLER HG; STOHLAWETZ P; SCHWARZINGER I; KAPIOTIS S; WAGNER OF
      EFFECTS OF ENDOTHELIN-1 ON CIRCULATING ADHESION MOLECULES IN MAN

      European journal of clinical investigation
    40. JILMA B; VOLTMANN J; ALBINNI S; STOHLAWETZ P; SCHWARZINGER I; GLEITER CH; RAUCH A; EICHLER HG; WAGNER OF
      DEXAMETHASONE DOWN-REGULATES THE EXPRESSION OF L-SELECTIN ON THE SURFACE OF NEUTROPHILS AND LYMPHOCYTES IN HUMANS

      Clinical pharmacology and therapeutics
    41. GEISSLER K; KOLLER E; HUBMANN E; NIEDERWIESER D; HINTERBERGER W; GEISSLER D; KYRLE P; KNOBL P; PABINGER I; THALHAMMER R; SCHWARZINGER I; MANNHALTER C; JAEGER U; HEINZ R; LINKESCH W; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY

      Blood
    42. SPERR WR; WALCHSHOFER S; HORNY HP; FODINGER M; CHOTT A; SIMONITSCH I; SILLABER C; SCHWARZINGER I; TSCHACHLER E; GEISSLER K; LECHNER K; VALENT P
      DETECTION OF THE C-KIT POINT MUTATION ASP-]VAL-[816] IN SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH AML

      Blood
    43. KALHS P; REITER E; KEIL F; SCHULENBURG A; ROSENMAYR A; FISCHER G; DIECKMANN K; KURZ M; SCHWARZINGER I; LECHNER K; GREINIX HT
      LOW TRANSPLANT-RELATED MORTALITY (TRM) IN UNRELATED DONOR (UD) MARROWGRAFT RECIPIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCY

      Blood
    44. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Blood
    45. SPERR WR; PIRIBAUER M; AGIS H; MITTERBAUER M; GEISSLER K; HAAS O; FONATSCH C; JAGER U; SCHWARZINGER I; THALHAMMER F; VALENT P; LECHNER K
      INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY

      Blood
    46. THALHAMMERSCHERRER R; KNOBL P; KORNINGER L; SCHWARZINGER I
      AUTOMATED 5-PART WHITE-BLOOD-CELL DIFFERENTIAL COUNTS - EFFICIENCY OFSOFTWARE-GENERATED WHITE-BLOOD-CELL SUSPECT FLAGS OF THE HEMATOLOGY-ANALYZERS SYSMEX-SE-9000, SYSMEX-NE-8000, AND COULTER-STKS

      Archives of pathology and laboratory medicine
    47. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
      FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    48. MITTERBAUER M; FRITZERSZEKERES M; MITTERBAUER G; SIMONITSCH I; KNOBL P; RINTELEN C; SCHWARZINGER I; HAAS OA; SILBERBAUER K; FREY K; BIBUS B; PABINGER I; RADASZKIEWICZ T; LECHNER K; JAEGER U
      SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA

      Annals of hematology
    49. GREINIX HT; KEIL F; BRUGGER SA; REITER E; LINKESCH W; LECHNER K; SCHNEIDER B; DIECKMANN KU; FISCHER G; SCHWARZINGER I; HAAS O; HINTERBERGER W; MANNHALTER C; GEISSLER K; HOCKER P; JAGER U; KALHS P
      LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    50. HAAS M; MANNHALTER C; ULLRICH R; SCHWARZINGER I; ZUCKERMANN A; DERFLER K; JAGER U
      A MULTILOCULAR B-CELL NEOPLASIA PRESENTING AS MULTIPLE-MYELOMA AND POLYMORPHIC LYMPHOMA OF RECIPIENT ORIGIN 2 MONTHS AFTER KIDNEY-TRANSPLANTATION IN A HEART-TRANSPLANT RECIPIENT

      Nephrology, dialysis, transplantation
    51. KEIL F; KALHS P; HAAS OA; FRITSCH G; MITTERBAUER G; BRUGGER S; LECHNER K; SCHWARZINGER I; MANNHALTER C; LINKESCH W; KURZ M; GREINIX HT
      GRAFT FAILURE AFTER DONOR LEUKOCYTE INFUSION IN RELAPSED CHRONIC MYELOID-LEUKEMIA - SUCCESSFUL TREATMENT WITH CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION

      British Journal of Haematology
    52. FODINGER M; BUCHMAYER H; SCHWARZINGER I; SIMONITSCH I; WINKLER K; JAGER U; KNOBLER R; MANNHALTER C
      MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

      British Journal of Haematology
    53. REITER E; BRUGGER S; KEIL F; MANNHALTER C; RABITSCH W; GREINIX HT; SCHWARZINGER I; SIMONITSCH S; VOLC B; LECHNER K; KALHS P
      GRAFT-VERSUS-HOST DISEASE FOLLOWING 2ND SYNGENEIC BMT FOR RELAPSED CML

      Blood
    54. KORNINGER L; KITZWEGER E; MUSTAFA G; SCHWARZINGER I
      SURFACE IMMUNOLOGICAL CHARACTERIZATION OF CHRONIC B-LYMPHOCYTIC LEUKEMIAS (B-CLLS) WITH ANTIBODIES OF THE BLIND B-CELL PANEL

      Tissue antigens
    55. SCHOLTEN C; FODINGER M; MITTERBAUER M; LACZIKA K; MITTERBAUER G; HAAS OA; KNOBL P; SCHWARZINGER I; THALHAMMER R; PURTSCHER B; GEISSLER K; MANNHALTER C; LECHNER K; JAEGER U
      KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Annals of hematology
    56. DELLEKARTH G; LACZIKA K; SCHOLTEN C; LECHNER K; JAEGER U; SCHWARZINGER I; SIMONITSCH I
      CLEARANCE OF PCR-DETECTABLE LYMPHOMA-CELLS FROM THE PERIPHERAL-BLOOD,BUT NOT BONE-MARROW AFTER THERAPY WITH CAMPATH-1H

      American journal of hematology
    57. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; SCHNEIDER B; HOCKER P; LINKESCH W; LECHNER K
      MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

      Transplantation
    58. MITTERBAUER G; FODINGER M; SCHERRER R; KNOBL P; JAGER U; LACZIKA K; SCHWARZINGER I; GAIGER A; GEISSLER K; GREINIX H; KALHS P; LINKESCH W; LECHNER K; MANNHALTER C
      PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA

      British Journal of Haematology
    59. KALHS P; SCHWARZINGER I; ANDERSON G; MORI M; CLIFT RA; STORB R; BUCKNER CD; APPELBAUM FR; HANSEN JA; SULLIVAN KM
      A RETROSPECTIVE ANALYSIS OF THE LONG-TERM EFFECT OF SPLENECTOMY ON LATE INFECTIONS, GRAFT-VERSUS-HOST DISEASE, RELAPSE, AND SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    60. MITTERBAUER M; MITTERBAUER G; PIRCDANOEWINATA H; SCHWARZINGER I; KUSEC R; OHLER L; SCHWARZMEIER J; GEISSLER K; HAAS OA; LECHNER K; JAEGER U
      PCR-DETECTION OF AML1 ETO CHIMERIC TRANSCRIPTS IN MYELODYSPLASTIC SYNDROMES WITHOUT PROGRESSION TO ACUTE-LEUKEMIA/

      Blood
    61. SPERR WR; AGIS H; PIRIBAUER M; SEMPER H; SCHWARZINGER I; PABINGER I; WATZKE H; GEISSLER K; VALENT P; LECHNER K
      CYCLIC CHANGES OF GRANULOCYTE COUNTS DURING AND AFTER CONSOLIDATION TREATMENT WITH HIGH-DOSE ARA-C (HIDAC)

      Blood
    62. MITTERBAUER G; SCHWARZMEIER J; MITTERBAUER M; JAEGER U; FRITSCH G; SCHWARZINGER I
      MYELODYSPLASTIC SYNDROME (MDS) SUPERVENING PREVIOUSLY UNTREATED CHRONIC B-CELL LEUKEMIA (B-CLL) - DEMONSTRATION OF CONCOMITANT PRESENCE OF A CD19+ IMMUNOGLOBULIN (IG)-REARRANGEMENT POSITIVE B-CELL CLONE AND A CD34+/AML1-ETO POSITIVE BLAST CELL CLONE/

      Blood
    63. FODINGER M; SPEISER W; KARABENTCHEVA S; SCHERRER R; VEITL M; SCHWARZINGER I
      EVALUATION OF A TOTAL HEMATOLOGY ANALYSIS SYSTEM (SYSMEX HS-430) - BENEFITS FOR LARGE LABORATORIES BY REDUCING MANUAL WORK LOAD AND OPTIMIZING SCREENING EFFICACY FOR PATHOLOGICAL SAMPLES

      American journal of clinical pathology
    64. SCHERRER R; BETTELHEIM P; GEISSLER K; JAGER U; KNOBL P; KYRLE PA; LACZIKA K; MITTERBAUER G; NEUMANN E; SCHNEIDER B; SCHWARZINGER I; LECHNER K
      HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY

      Annals of hematology
    65. KUSEC R; LACZIKA K; KNOBL P; FRIEDL J; GREINIX H; KAHLS P; LINKESCH W; SCHWARZINGER I; MITTERBAUER G; PURTSCHER B; HAAS OA; LECHNER K; JAEGER U
      AML1 ETO FUSION MESSENGER-RNA CAN BE DETECTED IN REMISSION BLOOD-SAMPLES OF ALL PATIENTS WITH T(821) ACUTE MYELOID-LEUKEMIA AFTER CHEMOTHERAPY OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION/

      Leukemia
    66. LACZIKA K; MITTERBAUER G; KORNINGER L; KNOBL P; SCHWARZINGER I; KAPIOTIS S; HAAS OA; KYRLE PA; PONT J; OEHLER L; PURTSCHER B; THALHAMMER F; LECHNER K; JAEGER U
      RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY

      Leukemia
    67. GREINIX HT; LINKESCH W; KEIL F; KALHS P; SCHWARZINGER I; SCHNEIDER B; OESTERREICHER C; BRUGGER S; KAPIOTIS S; LECHNER K
      EARLY DETECTION OF HEMATOPOIETIC ENGRAFTMENT AFTER BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION BY HIGHLY FLUORESCENT RETICULOCYTE COUNTS

      Bone marrow transplantation
    68. SCHWARZINGER I; RAFF RF; FLOWERS M; NIEDERWIESER D; GRAHAM T; SHULMAN H; APPELBAUM FR; SCHUENING F; STORB R
      RECIPIENT-SPECIFIC DONOR CYTOTOXIC T-LYMPHOCYTES ENHANCE ENGRAFTMENT OF UNRELATED, DLA NONIDENTICAL CANINE MARROW

      Bone marrow transplantation
    69. ZOCHBAUER S; HAAS OA; SCHWARZINGER I; LECHNER K; PIRKER R
      MULTIDRUG-RESISTANCE IN ACUTE MYELOID-LEUKEMIA WITH INVERSION IN CHROMOSOME-16 OR FAB M4EO SUBTYPE

      Lancet
    70. KAPIOTIS S; QUEHENBERGER P; SENGOELGE G; PARTAN C; EHER R; STROBL H; BEVEC D; ZAPOLSKA D; SCHWARZINGER I; SPEISER W
      MODULATION OF PYROGEN-INDUCED UP-REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES (CAMS) BY INTERLEUKIN-4 - TRANSCRIPTIONAL MECHANISMS ANDCAM-SHEDDING

      Circulatory shock
    71. KAPIOTIS S; QUEHENBERGER P; EICHLER HG; SCHWARZINGER I; PARTAN C; SCHNEIDER B; LECHNER K; SPEISER W
      EFFECT OF HYDROXYETHYL STARCH ON THE ACTIVITY OF BLOOD-COAGULATION AND FIBRINOLYSIS IN HEALTHY-VOLUNTEERS - COMPARISON WITH ALBUMIN

      Critical care medicine
    72. KORNINGER L; KNOBL P; LACZIKA K; MUSTAFA S; QUEHENBERGER P; SCHWARZINGER I; LECHNER K; JAEGER U; MANNHALTER C
      PML-RAR-ALPHA PCR POSITIVITY IN THE BONE-MARROW OF PATIENTS WITH APL PRECEDES HEMATOLOGICAL RELAPSE BY 2-3 MONTHS

      British Journal of Haematology
    73. GEISSLER K; KOLLER E; HINTERBERGER W; NIEDERWIESER D; KNOBL P; PABINGER I; WERNER D; SCHERRER R; SCHWARZINGER I; FRIEDL J; JAEGER U; LECHNER K
      CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY INRANDOMIZED PARALLEL GROUPS

      Blood
    74. SANDMAIER BM; BASTIANELLI C; SANTOS E; SCHWARZINGER I; RAFF R; STORB R
      EVALUATION OF PERIPHERAL-BLOOD MONONUCLEAR CELL DOSE AND T-CELL SUBPOPULATION REQUIRED FOR ENHANCEMENT OF ENGRAFTMENT IN UNRELATED DOG LEUKOCYTE ANTIGEN (DLA) NONIDENTICAL MARROW TRANSPLANTS

      Blood
    75. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; LINKESCH W; LECHNER K
      SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

      Blood
    76. MITTERBAUER M; KUSEC R; STROBL H; SCHEINECKER C; OEHLER L; SCHWARZINGER I; GEISSLER K; HAAS OA; KNAPP W; LECHNER K
      LOCALIZATION OF AML1 ETO-TRANSCRIPTS IN A CD56+ LEUKOCYTE SUBSET AND IN THE CFU-GM PERIPHERAL STEM-CELL FRACTION IN PATIENTS WITH T(8-21)-POSITIVE ACUTE MYELOID-LEUKEMIA IN REMISSION/

      Blood
    77. SCHWARZINGER I; FODINGER M; SCHERRER R; WOLZT M; MANNHALTER C; SPEISER W
      HYPERGRANULAR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - REPORT OF A CASE AND REVIEW OF THE LITERATURE

      Annals of hematology
    78. LORBER C; WILLFORT A; OHLER L; JAGER U; SCHWARZINGER I; LECHNER K; GEISSLER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF) AS AN ADJUNCT TO INTERFERON-ALPHA THERAPY OF NEUTROPENIC PATIENTS WITH HAIRY-CELL LEUKEMIA

      Annals of hematology
    79. SCHERRER R; GEISSLER K; KYRLE PA; GISSLINGER H; JAGER U; BETTELHEIM P; LACZIKA K; LOCKER G; SCHOLTEN C; SILLABER C; SCHWARZINGER I; THALHAMMER F; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Annals of hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 07:42:32